Revista: | Anais brasileiros de dermatologia |
Base de datos: | PERIÓDICA |
Número de sistema: | 000385693 |
ISSN: | 0365-0596 |
Autores: | Quaresma, Maria Victoria1 Bernardes-Filho, Fred1 Oliveira, Fernanda Brandao de1 Pockstaller, Mercedes Prates1 Dias, Maria Fernanda Reis Gavazzoni1 Azulay, David Rubem1 |
Instituciones: | 1Santa Casa da Misericordia do Rio de Janeiro, Instituto de Dermatologia Professor Rubem David Azulay, Rio de Janeiro. Brasil |
Año: | 2015 |
Periodo: | May-Jun |
Volumen: | 90 |
Número: | 3 |
Paginación: | 123-127 |
País: | Brasil |
Idioma: | Inglés |
Tipo de documento: | Artículo |
Enfoque: | Caso clínico, descriptivo |
Resumen en inglés | Drug-induced lupus is a rare drug reaction featuring the same symptoms as idiopathic lupus erythematosus. Recently, with the introduction of new medicines in clinical practice, an increase in the number of illness-triggering implicated drugs has been reported, with special emphasis on anti-TNF-α drugs. In the up-to-date list, almost one hundred medications have been associated with the occurrence of drug-induced lupus. The authors present two case reports of the illness induced respectively by hydralazine and infliximab, addressing the clinical and laboratorial characteristics, diagnosis, and treatment |
Disciplinas: | Medicina |
Palabras clave: | Dermatología, Farmacología, Infliximab, Hidralazina, Efectos adversos, Lupus eritematoso cutáneo |
Keyword: | Medicine, Dermatology, Pharmacology, Infliximab, Hydralazine, Adverse effects, Cutaneous lupus erythematosus |
Texto completo: | Texto completo (Ver HTML) |